ORAL-ADMINISTRATION OF HUMAN RECOMBINANT INTERFERON-ALPHA-2 IN RATS

被引：15
|
作者：
PAULESU, L [1 ]
CORRADESCHI, F [1 ]
NICOLETTI, C [1 ]
BOCCI, V [1 ]
机构：
[1] UNIV SIENA,INST GEN PHYSIOL,VIA LATERINA 8,I-53100 SIENA,ITALY
来源：
INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1988年 / 46卷 / 03期
关键词：
D O I：
10.1016/0378-5173(88)90078-6
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：199 / 202
页数：4
相关论文
共 50 条
  • [41] ORAL-ADMINISTRATION OF ASPARTAME IS NOT PROCONVULSANT IN RATS
    TILSON, HA
    THAI, L
    ZHAO, D
    SOBOTKA, TJ
    HONG, JS
    NEUROTOXICOLOGY, 1989, 10 (02) : 229 - 238
  • [42] THE ORAL-ADMINISTRATION OF STANNOUS CHLORIDE TO RATS
    YAMAGUCHI, M
    KITADE, M
    OKADA, S
    TOXICOLOGY LETTERS, 1980, 5 (3-4) : 275 - 278
  • [43] INTERFERON-ALPHA-2 IN THE TREATMENT OF IDIOPATHIC MYELOFIBROSIS
    SEEWANN, HL
    GASTL, G
    LANG, A
    ABBREDERIS, K
    THALER, J
    FLENER, R
    HUBER, C
    BLUT, 1988, 56 (04): : 161 - 163
  • [44] DIFFERENT BINDING OF HUMAN INTERFERON-ALPHA-1 AND INTERFERON-ALPHA-2 TO COMMON RECEPTORS ON HUMAN AND BOVINE CELLS - STUDIES WITH RECOMBINANT INTERFERONS PRODUCED IN ESCHERICHIA-COLI
    YONEHARA, S
    YONEHARATAKAHASHI, M
    ISHII, A
    NAGATA, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1983, 258 (15) : 9046 - 9049
  • [45] HEMATOLOGICAL AND GENETIC-STUDIES ON CML PATIENTS DURING TREATMENT WITH RECOMBINANT INTERFERON-ALPHA-2
    GASTL, G
    LEITER, E
    AULITZKY, W
    TILG, H
    VONLUTTICHAU, I
    RAPP, U
    HUBER, C
    ACTA MEDICA AUSTRIACA, 1986, 13 : 67 - 67
  • [46] A TRIAL OF RECOMBINANT INTERFERON-ALPHA-2 IN THE MYELODYSPLASTIC SYNDROMES .1. CLINICAL-RESULTS
    ELIAS, L
    HOFFMAN, R
    BOSWELL, S
    TENSEN, L
    BONNEM, EM
    LEUKEMIA, 1987, 1 (02) : 105 - 110
  • [47] EXPRESSION OF MUTANT HUMAN INTERFERON-ALPHA-2 IN ESCHERICHIA-COLI-CELLS
    OVCHINNIKOV, YA
    SVERDLOV, ED
    MONASTYRSKAYA, GS
    TSAREV, SA
    ZAITSEVA, EM
    ARSENYAN, SG
    CHAKHMAKHCHEVA, OG
    NOVOKHATSKII, AS
    ASPETOV, RD
    KUZNETSOV, VP
    MOLECULAR BIOLOGY, 1984, 18 (01) : 36 - 45
  • [48] PHASE-I STUDY - RECOMBINANT INTERFERON-ALPHA-2 IN CHEMOTHERAPY-RESISTANT NEOPLASIAS
    LUDWIG, H
    SCHEITHAUER, W
    FLENER, R
    SWETLY, P
    JANSSEN, J
    DEPAUW, B
    BLUT, 1984, 49 (03): : 267 - 268
  • [49] ORAL-ADMINISTRATION OF HUMAN OR MURINE INTERFERON-ALPHA SUPPRESSES RELAPSES AND MODIFIES ADOPTIVE TRANSFER IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
    BROD, SA
    KHAN, M
    KERMAN, RH
    PAPPOLLA, M
    JOURNAL OF NEUROIMMUNOLOGY, 1995, 58 (01) : 61 - 69
  • [50] IMMUNOMODULATION BY RECOMBINANT INTERFERON-ALPHA-2 IN A PHASE-I TRIAL IN PATIENTS WITH LYMPHOPROLIFERATIVE MALIGNANCIES
    OZER, H
    GAVIGAN, M
    OMALLEY, J
    THOMPSON, D
    DADEY, B
    NUSSBAUMBLUMENSON, A
    SNIDER, C
    RUDNICK, S
    FERRARESI, R
    NORRED, S
    HAN, T
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1983, 2 (06): : 499 - 515
12345